BAT Releases glo HYPER PRO in Bosnia and Herzegovina

BAT by 2FIRSTS.ai
Jun.21.2024
BAT Releases glo HYPER PRO in Bosnia and Herzegovina
British American Tobacco (BAT) launched its latest heated tobacco device, glo HYPER PRO, in Bosnia and Herzegovina on June 20th.

According to a report by Bljesak.Info on June 20th, British American Tobacco (BAT) unveiled its latest heated tobacco device, glo HYPER PRO, for the first time in Bosnia and Herzegovina.

 

Previously, glo HYPER PRO had been launched in Croatia, Serbia, Italy, Poland, Japan, and other countries. With the launch of glo HYPER PRO, BAT became the first tobacco company to offer all categories of smokeless products (including e-cigarettes, nicotine pouches, and the current glo HYPER PRO heated tobacco product) in the Bosnian market. The company claims that these are also important steps towards BAT's commitment to creating "A Better Tomorrow™" and realizing its vision of a smoke-free world. The company's strategic goal is to shift smokers from traditional tobacco products to lower-risk alternative products, with the aim of becoming the leading company in the smokeless industry by 2035.

 

Furthermore, BAT emphasized its significant contribution to the economy of Bosnia and Herzegovina. BAT has operations in the country, including corporate offices and iNovina, as well as over 400 iNovina kiosks nationwide. In addition, they directly employ over 1000 people in Bosnia and Herzegovina, providing more job opportunities for locals. In 2023, they contributed 336 million convertible marks (KM) to the national budget of Bosnia and Herzegovina.

 

BAT Bosnia and Herzegovina director Johan Baguca stated that

 

The glo HYPER PRO is not just a device, but a perfect combination of technological innovation and exquisite design. Its aim is to introduce new technologies, such as smart LED screens and the HeatBoost induction heating system... For us, the most important thing is the satisfaction of nearly nine million adult glo users worldwide. We believe that this device will be well-received in Bosnia and Herzegovina and will certainly further enhance our position as the only company in the industry to offer a full range of low-risk smoke-free products in the country.

 

The General Manager of BAT Adriatic Region, Zvonko Kolobara, stated

 

I am proud of the launch of our glo HYPER PRO device, which has fully encompassed the low risk product category in the entire Adriatic region market, including Bosnia and Herzegovina, within our BAT product line. This is crucial for BAT and our future business. The key is that we need to offer as wide a range as possible of lower risk alternative products for our consumers, adult smokers. Over the past three years, BAT has invested over 1.4 billion euros in research and development, commercialization, and scientific studies to support its portfolio of lower risk tobacco and nicotine products. These efforts are crucial, as clear regulatory frameworks are needed to differentiate between tobacco and lower risk products and understand the potential of these alternatives for adult smokers.

 

Currently, the glo HYPER PRO device is now available for purchase at iNovina newsstands and other retail locations in Bosnia and Herzegovina.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire reported a sharp year-on-year revenue decline in Q2 FY2026 as it shifted away from lower-quality customers, while cutting operating expenses and narrowing its net loss. The company also highlighted improved collections, with net accounts receivable down nearly one-fifth since June 30, 2025, alongside ongoing manufacturing and technology initiatives.
Feb.09 by 2FIRSTS.ai
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
Philippine DTI Says Flavored Vape Products With Minor-Appealing Descriptors Are “100 Percent Smuggled”
Philippine DTI Says Flavored Vape Products With Minor-Appealing Descriptors Are “100 Percent Smuggled”
A Philippine Department of Trade and Industry official told a Senate hearing on vaping regulations that flavored vape products marketed with descriptors attractive to minors are “100 percent smuggled” and did not pass the agency’s licensing process.
Mar.16 by 2FIRSTS.ai
South Korea’s Seoul Gangnam District Installs “Separated Smoking Booths” , Splitting Cigarettes and Vapes
South Korea’s Seoul Gangnam District Installs “Separated Smoking Booths” , Splitting Cigarettes and Vapes
Seoul's Gangnam district introduces smoking booths on Tehran Road to combat public smoking and secondhand smoke issues.
Jan.23 by 2FIRSTS.ai
New York Proposal to Tax Nicotine Pouches at 75% Draws Opposition
New York Proposal to Tax Nicotine Pouches at 75% Draws Opposition
A proposal by New York Governor Kathy Hochul to impose a steep tax on nicotine pouches has drawn opposition from law-enforcement officials and business groups, who say it could expand the state’s illicit tobacco market. The measure was included in Hochul’s preliminary two-year USD 260 billion budget plan and would treat nicotine pouches like other tobacco products.
Mar.17 by 2FIRSTS.ai